CA2661538A1 - Novel macrolides and ketolides having antimicrobial activity - Google Patents

Novel macrolides and ketolides having antimicrobial activity Download PDF

Info

Publication number
CA2661538A1
CA2661538A1 CA002661538A CA2661538A CA2661538A1 CA 2661538 A1 CA2661538 A1 CA 2661538A1 CA 002661538 A CA002661538 A CA 002661538A CA 2661538 A CA2661538 A CA 2661538A CA 2661538 A1 CA2661538 A1 CA 2661538A1
Authority
CA
Canada
Prior art keywords
compound
formula
phenyl
pyridin
oxadiazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002661538A
Other languages
English (en)
French (fr)
Inventor
Milind Dattatraya Sindkhedkar
Vijaya Narayan Desai
Rajesh Maganlal Loriya
Mahesh Vithalbhai Patel
Bharat Kalidas Trivedi
Rajesh Onkardas Bora
Santosh Devidas Diwakar
Ganesh Rajaram Jadhav
Shivaji Sampatrao Pawar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wockhardt Research Centre
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2661538A1 publication Critical patent/CA2661538A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CA002661538A 2006-08-24 2007-08-22 Novel macrolides and ketolides having antimicrobial activity Abandoned CA2661538A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1336/MUM/2006 2006-08-24
IN1336MU2006 2006-08-24
PCT/IB2007/002405 WO2008023248A2 (en) 2006-08-24 2007-08-22 Novel macrolides and ketolides having antimicrobial activity

Publications (1)

Publication Number Publication Date
CA2661538A1 true CA2661538A1 (en) 2008-02-28

Family

ID=39107171

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002661538A Abandoned CA2661538A1 (en) 2006-08-24 2007-08-22 Novel macrolides and ketolides having antimicrobial activity

Country Status (7)

Country Link
US (1) US8097594B2 (https=)
EP (1) EP2056844A4 (https=)
JP (1) JP2010501541A (https=)
KR (1) KR20090042971A (https=)
CN (1) CN101541331A (https=)
CA (1) CA2661538A1 (https=)
WO (1) WO2008023248A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008293542B9 (en) 2007-08-27 2014-08-07 Dart Neuroscience (Cayman) Ltd. Therapeutic isoxazole compounds
US8410277B2 (en) 2007-12-26 2013-04-02 Eisai R&D Managment Co., Ltd. Method for manufacturing heterocycle substituted pyridine derivatives
BRPI1011959A2 (pt) 2009-05-27 2016-04-26 Wockhardt Research Center compostos de cetolídeo tendo atividade antimicrobiana.
WO2012076989A1 (en) 2010-12-09 2012-06-14 Wockhardt Limited Ketolide compounds
KR101567658B1 (ko) 2011-03-01 2015-11-09 욱크하르트 리미티드 케톨리드 중간체의 제조 방법
CN103619863B (zh) * 2011-03-22 2016-03-16 沃克哈特有限公司 酮内酯化合物的制备方法
WO2012129564A2 (en) 2011-03-24 2012-09-27 H. Lee Moffitt Cancer Center And Research Institute, Inc. Proteasome chymotrypsin-like inhibition using pi-1833 analogs
CN102260225B (zh) * 2011-06-02 2013-08-21 蒋杰 用于抑制肿瘤转移和肿瘤血管生长的苯基哌嗪类衍生物
US10633407B2 (en) * 2014-10-08 2020-04-28 President And Fellows Of Harvard College 14-membered ketolides and methods of their preparation and use
KR20190129863A (ko) * 2017-03-16 2019-11-20 욱크하르트 리미티드 케톨라이드 화합물의 제조 방법
ES2948122A1 (es) * 2022-02-10 2023-08-31 Fundacion Instituto De Investig Sanitaria Aragon Compuestos para el tratamiento y/o prevención de una infección o enfermedad causada por Helicobacter o Campylobacter

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4331803A (en) 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
FR2719587B1 (fr) 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
DE69733723T2 (de) 1996-09-04 2006-04-20 Abbott Laboratories, Abbott Park 6-o-Substituierte Ketoliden mit antibakteriellen Wirkung
BR0113472A (pt) 2000-08-22 2003-07-01 Basilea Pharmaceutica Ag Macrolìdeos com atividade antibacteriana
GB0031312D0 (en) 2000-12-21 2001-02-07 Glaxo Group Ltd Macrolides
CN1492874A (zh) 2000-12-21 2004-04-28 大环内酯
WO2003008411A1 (en) 2001-07-19 2003-01-30 Cv Therapeutics, Inc. Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
US6995143B2 (en) 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US6727229B2 (en) 2002-08-19 2004-04-27 Enanta Pharmaceuticals, Inc. 11,12-substituted lactone ketolide derivatives having antibacterial activity
AU2006212626B2 (en) * 2005-02-09 2010-04-29 Basilea Pharmaceutica Ag New macrolides

Also Published As

Publication number Publication date
JP2010501541A (ja) 2010-01-21
EP2056844A4 (en) 2010-11-24
US8097594B2 (en) 2012-01-17
WO2008023248A3 (en) 2009-04-23
WO2008023248A2 (en) 2008-02-28
EP2056844A2 (en) 2009-05-13
CN101541331A (zh) 2009-09-23
KR20090042971A (ko) 2009-05-04
US20090247478A1 (en) 2009-10-01

Similar Documents

Publication Publication Date Title
CA2661538A1 (en) Novel macrolides and ketolides having antimicrobial activity
CN108602776B (zh) 用作irak抑制剂的杂芳基化合物及其用途
US6166056A (en) Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings
AU2014217453B2 (en) Heterocyclic amides as kinase inhibitors
CN108290879B (zh) 用作irak抑制剂的杂芳基化合物及其用途
ES2642287T3 (es) Compuestos cetólidos
AU748750B2 (en) Novel isoxazolinone antibacterial agents
ES2217329T3 (es) Agente antibacteriano de oxazolidinona con sustituyentes triciclicos.
JP2011513216A (ja) 複素環式尿素誘導体及びその使用の方法−211
JP2010501541A5 (https=)
US6281210B1 (en) Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent
JP2000159790A (ja) 新規のエリスロマイシン誘導体、それらの製造方法及びそれらの薬剤としての使用
CA2616977A1 (en) Oxazolidinone-quinolone hybrids as antibacterial compounds
JP7112963B2 (ja) セコマクロライド化合物
EP1549641A1 (en) Antimicrobial 3.1.0 bicyclic oxazolidinone derivatives
CA2473076C (en) Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones
NZ611653B (en) Ketolide compounds
NZ611653A (en) Ketolide compounds
HK40009552A (en) Heterocyclic amides as kinase inhibitors
WO2013001830A1 (ja) 核酸抗生物質誘導体

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20130923